Clinical Manifestations
Pathophysiology
Diagnosis
Treatment
Miscellaneous
100

Most prevalent in child cases, the presence of visible blood in the urine, causing pink discoloration

Macroscopic hematuria

100

Failure to regulate the alternative pathway of the complement system. This causes the system to attack the body's own cells (glomeruli)

Alternative Pathway Dysregulation

100

Tests for nephritic factors that drive the disease by keeping the immune system turned "ON"

Autoantibody Screening

100

Medicines that target the complement system

Complement Inhibitors

100

This age group is the most commonly affected by this disorder

Young adults

200

A rare manifestation that involves the uneven fat loss, most prevalent in the face or upper body

Acquired Partial Lipodystrophy (APL)

200

Hallmark manifestation involves prominent deposition of complement component C3, with absent or low immunoglobulin, on a renal biopsy

C3 Deposition

200

Used to establish between the two subtypes of C3 (complement protein), more dense and less dense, via structure differences

Electron Microscopy

200

Treatment that filters waste, toxins, and excess fluid from the blood

Dialysis

200

This process refers to the filtration of blood in the kidneys

Glomerular Filtration

300

Build-up of complement proteins in the eyes, which may cause impaired vision

Ocular Drusen

300

A rare change in fat distribution, particularly in the face and upper body

Lipodystrophy

300

Testing for low C3 in the urine via a urine or blood test

Hypocomplementura

300

A process that filters blood to remove harmful antibodies by separating plasma from blood

Plasma Exchange

300

This is the functional unit of the kidney that is responsible for filtrations

Nephron

400

Increased serum creatinine, reduced estimated glomerular filtration rate (eGFR), and decreased urine

Reduced kidney function
400

Accumulation of C3 in the glomerular basement membrane triggers damage

Glomerular Inflammation and Scarring

400

Testing for functional abnormalities in complement system proteins, and test for underlying causative genetic mutations.

Complement System evaluation

400

Medications that help control blood pressure and reduce protein loss

ACE Inhibitors

400

This organ is responsible for filtering blood to remove waste and excess

Kidney

500

Presence of excess protein in the urine, giving it a foamy or bubbly appearance

Proteinuria

500

Disruption of the alternative pathway of activation due to the presence of autoantibodies - antibodies that recognize the host's own tissues 

Complement Dysfunction

500

Dominant C3 staining is visible in immunofluorescence microscopy, giving a definitive diagnosis

Kidney Biopsy

500

These drugs suppress the immune system and stop it from attacking the kidney

Immunosuppressants

500

This is the primary organ system that is affected by this disorder

Urinary System

M
e
n
u